Medicine and Dentistry
COVID-19
100%
Infection
33%
Human Immunodeficiency Virus
31%
Comorbidity
27%
Tocilizumab
26%
Severe Acute Respiratory Syndrome Coronavirus 2
26%
Pericarditis
26%
Serositis
26%
Diseases
25%
Prevalence
19%
Drug Resistance
16%
Diabetes
15%
Sepsis
13%
Low Drug Dose
13%
Cohort Analysis
13%
Kikuchi Disease
13%
Pneumococcus Vaccine
13%
Tuberculous Lymphadenitis
13%
Immunoglobulin G Antibody
13%
Population Research
13%
Resistance Mutation
13%
Pediatrics
13%
Symptomatic Treatment
13%
Antibiotic Resistance
13%
Virus Nucleocapsid
13%
Anakinra
13%
Streptococcus Pneumonia
13%
Noninferiority Trial
13%
Lung
13%
Seroprevalence
13%
Group Therapy
13%
Rilpivirine
13%
Cabotegravir
13%
Immunoglobulin
13%
Pneumococcal Pneumonia
13%
Radiation Therapy
13%
Artificial Respiration
11%
Lymphadenopathy
9%
Antibiotics
9%
Placebo
8%
Non Communicable Disease
8%
Odds Ratio
8%
Methylprednisolone
8%
Disability Adjusted Life Years
8%
Coughing
7%
Diagnosis
6%
Tuberculosis Treatment
6%
Intensive Care
6%
Acute Respiratory Failure
6%
Systemic Lupus Erythematosus
6%
Pharmacology, Toxicology and Pharmaceutical Science
Diseases
60%
HIV
42%
Histoplasmosis
39%
Comorbidity
32%
Prevalence
32%
Infection
26%
Sepsis
26%
Combination Therapy
18%
Cohort Study
13%
Coronavirinae
13%
Tocilizumab
13%
SARS Coronavirus
13%
Pneumococcus Vaccine
13%
Immunoglobulin G Antibody
13%
Antimicrobial Resistance
13%
Ferritin
13%
Systemic Treatment
13%
Acute Toxicity
13%
Phase II Trials
13%
Clinical Trial
13%
D Dimer
13%
Drug Resistance
13%
Dexamethasone
13%
Cytokine Storm
13%
Seroprevalence
13%
Streptococcus Pneumonia
13%
Placebo
8%
Non Communicable Disease
8%
Antibiotics
6%
Coughing
6%
Mixed Infection
5%
Disease Severity
5%
Nursing and Health Professions
Comorbidity
32%
Tertiary Care Center
26%
Health Care Personnel
17%
Severe Acute Respiratory Syndrome
17%
Cohort Analysis
13%
Pneumococcal Conjugate Vaccine
13%
Antimicrobial Resistance
13%
Immunoglobulin G Antibody
13%
Histoplasmosis
13%
Seroprevalence
13%
Sepsis
13%
Streptococcus Pneumonia
13%
Human Immunodeficiency Virus
10%
Confidence Interval
10%
Infection
9%
Non Communicable Disease
8%
Odds Ratio
8%
Disability-Adjusted Life Year
8%
Diseases
8%
Prevalence
5%
University Hospital
5%